Modelling Multi-Mutation and Drug Resistance: A case of Immune-Suppression

dc.contributor.authorKimathi, Mark E.
dc.contributor.authorTogbenon, Houenafa A.
dc.contributor.authorDegla, Guy A.
dc.date.accessioned2018-11-20T11:55:39Z
dc.date.available2018-11-20T11:55:39Z
dc.date.issued2018
dc.description.abstractA model that takes into account multi-mutation and drug resistance in a case of simple immune system and immune-suppression caused by drug resistant tumor cells is proposed. Since methods for revising therapeutic approaches (immunotherapy and chemotherapy) during cancer treatment are still being explored, we analyzed mathematically and simulated numerically with the aid of MATLAB software the corresponding tumor-immunotherapy model to determine the effectiveness of the immunotherapy. Through the mathematical analysis, the existence, the uniqueness and the boundedness of solutions are shown. The non-tumor states are stable, under conditions only in the presence of the immunotherapy drug and in the absence of the drug resistant tumor cells. The numerical results show the behavior of the tumor cells and immune system cells in the absence and in the presence of the immunotherapy drug. This study provides an efficient treatment strategie to cancer in the absence and in the presence of the drug resistant tumor cells.en_US
dc.identifier.issn0973-1768
dc.identifier.urihttp://ir.mksu.ac.ke/handle/123456780/1904
dc.language.isoenen_US
dc.publisherResearch India Publicationsen_US
dc.subjectCancer modelingen_US
dc.subjectDrug resistanceen_US
dc.subjectMutationen_US
dc.subjectImmune systemen_US
dc.subjectChemotherapyen_US
dc.titleModelling Multi-Mutation and Drug Resistance: A case of Immune-Suppressionen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
02_64340-GJPAMok787-807.pdf
Size:
4.12 MB
Format:
Adobe Portable Document Format
Description:
Full text

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: